This article is 2 years old
Conditional approval for Spikevax vaccine for 12-year-olds and above
COVID-19 | The Spikevax brand Covid-19 vaccine produced by Rovi Pharma Industrial Services in Spain has been given conditional approval for use in Malaysia by 12-year-olds and above, Health director-general Dr Noor Hisham Abdullah said.
He said the decision was made at the 375th Drug Control Authority (PBKD) meeting yesterday...
Verifying user
RM12.50 / month
- Unlimited access to award-winning journalism
- Comment and share your opinions on all our articles
- Gift interesting stories to your friends
- Tax deductable